{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:23:21Z","timestamp":1790717001002,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1136\/ijgc-2019-001168","type":"journal-article","created":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T13:59:32Z","timestamp":1590242372000},"page":"1397-1403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Factors associated with referral and completion of genetic counseling in women with epithelial ovarian cancer"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9130-4904","authenticated-orcid":false,"given":"Stephanie","family":"Alimena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Scarpetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica L","family":"Blouch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Shannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Del Carmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annekathryn","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitfield B","family":"Growdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Eisenhauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel Clark","family":"Sisodia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2019-001168_bb0010","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1136\/ijgc-2019-001168_bb0015","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"10.1136\/ijgc-2019-001168_bb0020","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/cncr.21536","article-title":"BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases","volume":"104","author":"Pal","year":"2005","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2019-001168_bb0025","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/AOG.0b013e31825f3576","article-title":"Germline BRCA1 and BRCA2 mutations in ovarian cancer: utility of a histology-based referral strategy","volume":"120","author":"Schrader","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2019-001168_bb0030","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1200\/JCO.2011.39.8545","article-title":"BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group","volume":"30","author":"Alsop","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2019-001168_bb0035","doi-asserted-by":"crossref","first-page":"18032","DOI":"10.1073\/pnas.1115052108","article-title":"Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing","volume":"108","author":"Walsh","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1136\/ijgc-2019-001168_bb0040","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/jnci\/djj465","article-title":"Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada","volume":"98","author":"Risch","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/ijgc-2019-001168_bb0045","author":"National Comprehensive Cancer Network","year":"2012","journal-title":"Genetic\/familial high risk assessment: breast and ovarian cancer. V2"},{"key":"10.1136\/ijgc-2019-001168_bb0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2014.09.009","article-title":"Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions","volume":"136","author":"Lancaster","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-001168_bb0055","doi-asserted-by":"crossref","first-page":"6275","DOI":"10.2147\/CMAR.S206817","article-title":"Frequency of germline mutations in BRCA1 and BRCA2 in ovarian cancer patients and their effect on treatment outcome","volume":"11","author":"Ashour","year":"2019","journal-title":"Cancer Manag Res"},{"key":"10.1136\/ijgc-2019-001168_bb0060","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1200\/JCO.2011.36.9215","article-title":"Phase II, open-label, randomized, multicenter study comparing the efficacy and safety of olaparib, a poly (ADP-ribose) polymerase inhibitor, and pegylated liposomal doxorubicin in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer","volume":"30","author":"Kaye","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2019-001168_bb0065","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1056\/NEJMoa1810858","article-title":"Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer","volume":"379","author":"Moore","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2019-001168_bb0070","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa0900212","article-title":"Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers","volume":"361","author":"Fong","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2019-001168_bb0075","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/1758834016687254","article-title":"PARP inhibitors in ovarian cancer: evidence, experience and clinical potential","volume":"9","author":"Evans","year":"2017","journal-title":"Ther Adv Med Oncol"},{"key":"10.1136\/ijgc-2019-001168_bb0080","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10689-016-9893-5","article-title":"Genetic counseling and cascade genetic testing in Lynch syndrome","volume":"15","author":"Hampel","year":"2016","journal-title":"Fam Cancer"},{"key":"10.1136\/ijgc-2019-001168_bb0085","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jamaoncol.2015.5495","article-title":"Inherited mutations in women with ovarian carcinoma","volume":"2","author":"Norquist","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1136\/ijgc-2019-001168_bb0090","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0738-3991(03)00122-8","article-title":"Breast cancer risk counseling improves women's functioning","volume":"53","author":"Bowen","year":"2004","journal-title":"Patient Educ Couns"},{"key":"10.1136\/ijgc-2019-001168_bb0095","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1200\/JCO.2004.04.086","article-title":"Impact of BRCA1\/BRCA2 counseling and testing on newly diagnosed breast cancer patients","volume":"22","author":"Schwartz","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2019-001168_bb0100","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.293.14.1729","article-title":"Racial differences in the use of BRCA1\/2 testing among women with a family history of breast or ovarian cancer","volume":"293","author":"Armstrong","year":"2005","journal-title":"JAMA"},{"key":"10.1136\/ijgc-2019-001168_bb0105","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1006\/pmed.2001.0920","article-title":"Knowledge, attitudes, and interest in breast-ovarian cancer gene testing: a survey of a large African-American kindred with a BRCA1 mutation","volume":"33","author":"Kinney","year":"2001","journal-title":"Prev Med"},{"key":"10.1136\/ijgc-2019-001168_bb0110","first-page":"361","article-title":"Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing","volume":"8","author":"Lerman","year":"1999","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1136\/ijgc-2019-001168_bb0115","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/1574887110666150127110314","article-title":"Genetic counseling for hereditary breast and ovarian cancer among Puerto Rican women living in the United States","volume":"9","author":"Scherr","year":"2014","journal-title":"Rev Recent Clin Trials"},{"key":"10.1136\/ijgc-2019-001168_bb0120","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/gim.2014.125","article-title":"Disparities in uptake of BRCA1\/2 genetic testing in a randomized trial of telephone counseling","volume":"17","author":"Butrick","year":"2015","journal-title":"Genet Med"},{"key":"10.1136\/ijgc-2019-001168_bb0125","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s10897-013-9598-y","article-title":"Genetic risk assessment for women with epithelial ovarian cancer: referral patterns and outcomes in a university gynecologic oncology clinic","volume":"22","author":"Petzel","year":"2013","journal-title":"J Genet Couns"},{"key":"10.1136\/ijgc-2019-001168_bb0130","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ygyno.2019.01.024","article-title":"Disparities in gynecologic cancer genetics evaluation","volume":"153","author":"Hinchcliff","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-001168_bb0135","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.cgh.2013.04.044","article-title":"Uptake of genetic testing by relatives of Lynch syndrome probands: a systematic review","volume":"11","author":"Sharaf","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1136\/ijgc-2019-001168_bb0140","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10549-015-3374-7","article-title":"Factors associated with genetic counseling and BRCA testing in a population-based sample of young black women with breast cancer","volume":"151","author":"Cragun","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.1136\/ijgc-2019-001168_bb0145","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000431352","article-title":"Referral of ovarian cancer patients for genetic counselling by oncologists: need for improvement","volume":"18","author":"Ricci","year":"2015","journal-title":"Public Health Genomics"},{"key":"10.1136\/ijgc-2019-001168_bb0150","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ygyno.2015.04.029","article-title":"Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals","volume":"138","author":"Febbraro","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-001168_bb0155","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1200\/JCO.2006.05.5889","article-title":"Disparities in genetic testing: thinking outside the BRCA box","volume":"24","author":"Hall","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2019-001168_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1300\/J077v18n02_01","article-title":"Genetic testing of African Americans for susceptibility to inherited cancers","volume":"18","author":"Matthews","year":"2000","journal-title":"J Psychosoc Oncol"},{"key":"10.1136\/ijgc-2019-001168_bb0165","first-page":"147","article-title":"Awareness of genetic testing for increased cancer risk in the year 2000 National Health Interview Survey","volume":"6","author":"Wideroff","year":"2003","journal-title":"Community Genet"},{"key":"10.1136\/ijgc-2019-001168_bb0170","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/004695800404100304","article-title":"MassHealth succeeds in expanding coverage for adults","volume":"41","author":"Long","year":"2004","journal-title":"Inquiry"},{"key":"10.1136\/ijgc-2019-001168_bb0175","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2019.37.15_suppl.1584","article-title":"Germline mutation profile among Hispanic women with epithelial ovarian cancer (EOC)","volume":"37","author":"Chavarri Guerra","year":"2019","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24006650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24006650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2019-001168","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:25:35Z","timestamp":1753233935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24006650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1048891X24006650"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2019-001168","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors associated with referral and completion of genetic counseling in women with epithelial ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2019-001168","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}